Patent details

EP1331933 Title: TIAGABINE FOR THE TREATMENT OF DIABETIC NEUROPATHY

Basic Information

Publication number:
EP1331933
PCT Application Number:
PCT/US/2001/051407
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP019862374
PCT Publication Number:
WO/2002/038144
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TIAGABINE FOR THE TREATMENT OF DIABETIC NEUROPATHY
French Title of Invention:
TIAGABINE DESTINEE AU TRAITEMENT DE NEUROPATHIE DIABETIQUE
German Title of Invention:
TIAGABINE ZUR BEHANDLUNG VON DIABETISCHER NEUROPATHIE
SPC Number:

Dates

Filing date:
19/10/2001
Grant date:
28/03/2007
EP Publication Date:
28/03/2007
PCT Publication Date:
16/05/2002
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/08/2003
EP B1 Publication Date:
28/03/2007
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
19/10/2007
Expiration date:
19/10/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
19/10/2001
 
 

Name:
ABBOTT LABORATORIES
Address:
D377/AP6D 100 Abbott Park Road, Abbott Park, IL 60064-6050, United States (US)

Inventor

1

Name:
GIARDINA William, J.
Address:
United States (US)

2

Name:
COLLINS Stephen, D.
Address:
United States (US)

3

Name:
DEATON Roger, L.
Address:
United States (US)

4

Name:
GILBERT Adrienne, L.
Address:
United States (US)

Priority

Priority Number:
693361
Priority Date:
20/10/2000
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/4436;
Filing date Document type Number of pages